"We thought having health insurance would even the field. Insured black women should have had the same rapid evaluation as insured white women, but that was not the case in our study," said Heather Hoffman, Ph.D., assistant professor of epidemiology and biostatistics at The George Washington University School of Public Health and Health Services.
Hoffman and colleagues conducted a retrospective, cohort study of 581 women with breast cancer. Women were examined between 1997 and 2009 at seven hospitals and clinics in Washington, D.C.
Diagnostic delay time was defined as the number of days from abnormal screening to diagnosis, and treatment delay time was defined as the number of days from diagnosis to treatment initiation.
According to Hoffman, the goal was to identify risk factors associated with delays in diagnosis. They found the following:
Based on the results of this study, the researchers suggested that outreach focus on all black women and uninsured white women to improve their diagnostic time, and the importance of medical follow-up should be explained to patients.
"Black women should be the focus of breast cancer screening outreach and follow-up because they experience greater delays in diagnosis and in treatment than white women, regardless of insurance status," said Hoffman. "We need to determine those barriers in insured black women and all uninsured women."
986. Factors contributing to health disparities among minority women: Uni
|Contact: Jeremy Moore|
American Association for Cancer Research